11 results on '"Dart RC"'
Search Results
2. Insufficient stocking of poisoning antidotes in hospital pharmacies.
- Author
-
Dart RC, Stark Y, Fulton B, Koziol-McLain J, Lowenstein SR, Dart, R C, Stark, Y, Fulton, B, Koziol-McLain, J, and Lowenstein, S R
- Abstract
Objective: To determine whether antidotes for poisoning and overdose are available in hospitals that provide emergency department care.Design: Written survey of hospital pharmacy directors, each of whom reported the amount currently in stock of 8 different antidotes: antivenin (Crotalidae) polyvalent, cyanide kit, deferoxamine mesylate, digoxin immune Fab, ethanol, naloxone hydrochloride, pralidoxime chloride, and pyridoxine hydrochloride.Participants: Pharmacy directors of all hospitals with emergency departments in Colorado, Montana, and Nevada.Main Outcome Measures: Proportions of hospitals with insufficient stocking of each antidote, defined as complete lack of the antidote or an amount inadequate to initiate treatment of 1 seriously poisoned 70-kg patient.Results: Questionnaires were mailed to 137 hospital pharmacy directors and 108 (79%) responded. Only 1 (0.9%) of the 108 hospitals stocked all 8 antidotes in adequate amounts. The rate of insufficient stocking for individual antidotes ranged from 2% (for naloxone) to 98% (for digoxin immune Fab). In a multiple regression analysis, smaller hospital size and lack of a formal review of antidote stocking were independent predictors of the number of antidotes stocked insufficiently.Conclusions: Insufficient stocking of antidotes is a widespread problem in Colorado, Montana, and Nevada. Although these states are served by a certified regional poison center, potentially lifesaving antidotes are frequently not available when and where they might be needed to treat a single poisoned patient. [ABSTRACT FROM AUTHOR]- Published
- 1996
- Full Text
- View/download PDF
3. Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement.
- Author
-
Dart RC, Mullins ME, Matoushek T, Ruha AM, Burns MM, Simone K, Beuhler MC, Heard KJ, Mazer-Amirshahi M, Stork CM, Varney SM, Funk AR, Cantrell LF, Cole JB, Banner W, Stolbach AI, Hendrickson RG, Lucyk SN, Sivilotti MLA, Su MK, Nelson LS, and Rumack BH
- Subjects
- Humans, Child, Acetaminophen, Acetylcysteine, Ambulatory Care methods, Evidence-Based Medicine, Canada epidemiology, Drug-Related Side Effects and Adverse Reactions, Poisons
- Abstract
Importance: The US and Canada currently have no formal published nationwide guidelines for specialists in poison information or emergency departments for the management of acetaminophen poisoning, resulting in significant variability in management., Objective: To develop consensus guidelines for the management of acetaminophen poisoning in the US and Canada., Evidence Review: Four clinical toxicology societies (America's Poison Centers, American Academy of Clinical Toxicology, American College of Medical Toxicology, and Canadian Association of Poison Control Centers) selected participants (n = 21). Led by a nonvoting chairperson using a modified Delphi method, the panel created a decision framework and determined the appropriate clinical management of a patient with acetaminophen poisoning. Unique to this effort was the collection of guidelines from most poison centers in addition to systematic collection and review of the medical literature. Comments from review by external organizations were incorporated before the guideline was finalized. The project began in March 2021 and ended in March 2023., Findings: The search retrieved 84 guidelines and 278 publications. The panel developed guidelines for emergency department management of single or repeated ingestion of acetaminophen. In addition, the panel addressed extended-release formulation, high-risk ingestion, coingestion of anticholinergics or opioids, age younger than 6 years, pregnancy, weight greater than 100 kg, and intravenous acetaminophen use. Differences from current US practice include defining acute ingestion as an ingestion presentation from 4 to 24 hours after overdose was initiated. A revised form of the Rumack-Matthew nomogram was developed. The term massive ingestion was replaced with the term high-risk ingestion and denoted by a specific nomogram line. Other recommendations include specific criteria for emergency department triage, laboratory evaluation and monitoring parameters, defining the role of gastrointestinal decontamination, detailed management of acetylcysteine treatment, associated adverse effects, and stopping criteria for acetylcysteine treatment, as well as criteria for consultation with a clinical toxicologist. Finally, specific treatment considerations, including acetylcysteine dosing, fomepizole administration, and considerations for extracorporeal elimination and transplant evaluation, were addressed., Conclusions and Relevance: This qualitative study provides a consensus statement on consistent evidence-based recommendations for medical, pharmacy, and nursing education and practice to optimize care of patients with acetaminophen poisoning.
- Published
- 2023
- Full Text
- View/download PDF
4. Evaluation of Cannabis Use Among US Adults During the COVID-19 Pandemic Within Different Legal Frameworks.
- Author
-
Black JC, Amioka E, Iwanicki JL, Dart RC, and Monte AA
- Subjects
- Adult, Humans, Pandemics, SARS-CoV-2, COVID-19, Cannabis, Medical Marijuana therapeutic use, Hallucinogens
- Published
- 2022
- Full Text
- View/download PDF
5. Association Between Prescription Opioid Therapy for Noncancer Pain and Hepatitis C Virus Seroconversion.
- Author
-
Wilton J, Wong S, Purssell R, Abdia Y, Chong M, Karim ME, MacInnes A, Bartlett SR, Balshaw RF, Gomes T, Yu A, Alvarez M, Dart RC, Krajden M, Buxton JA, and Janjua NZ
- Subjects
- Adult, British Columbia, Drug Prescriptions statistics & numerical data, Female, Hepatitis C complications, Humans, Male, Pain blood, Pain virology, Pharmacies statistics & numerical data, Proportional Hazards Models, Retrospective Studies, Seroconversion, Analgesics, Opioid therapeutic use, Hepacivirus, Opioid-Related Disorders virology, Pain drug therapy, Substance Abuse, Intravenous virology
- Abstract
Importance: Initiation of injection drug use may be more frequent among people dispensed prescription opioid therapy for noncancer pain, potentially increasing the risk of hepatitis C virus (HCV) acquisition., Objective: To assess the association between medically dispensed long-term prescription opioid therapy for noncancer pain and HCV seroconversion among individuals who were initially injection drug use-naive., Design, Setting, and Participants: A population-based, retrospective cohort study of individuals tested for HCV in British Columbia, Canada, with linkage to outpatient pharmacy dispensations, was conducted. Individuals with an initial HCV-negative test result followed by 1 additional test between January 1, 2000, and December 31, 2017, and who had no history of substance use at baseline (first HCV-negative test), were included. Participants were followed up from baseline to the last HCV-negative test or estimated date of seroconversion (midpoint between HCV-positive and the preceding HCV-negative test)., Exposures: Episodes of prescription opioid use for noncancer pain were defined as acute (<90 days) or long-term (≥90 days). Prescription opioid exposure status (long-term vs prescription opioid-naive/acute) was treated as time-varying in survival analyses. In secondary analyses, long-term exposure was stratified by intensity of use (chronic vs. episodic) and by average daily dose in morphine equivalents (MEQ)., Main Outcomes and Measures: Multivariable Cox regression models were used to assess the association between time-varying prescription opioid status and HCV seroconversion., Results: A total of 382 478 individuals who had more than 1 HCV test were included, of whom more than half were female (224 373 [58.7%]), born before 1974 (201 944 [52.8%]), and younger than 35 years at baseline (196 298 [53.9%]). Participants were followed up for 2 057 668 person-years and 1947 HCV seroconversions occurred. Of the participants, 41 755 people (10.9%) were exposed to long-term prescription opioid therapy at baseline or during follow-up. The HCV seroconversion rate per 1000 person-years was 0.8 among the individuals who were prescription opioid-naive/acute (1489 of 1947 [76.5%] seroconversions; 0.4% seroconverted within 5 years) and 2.1 with long-term prescription opioid therapy (458 of 1947 [23.5%] seroconversions; 1.1% seroconverted within 5 years). In multivariable analysis, exposure to long-term prescription opioid therapy was associated with a 3.2-fold (95% CI, 2.9-3.6) higher risk of HCV seroconversion (vs prescription opioid-naive/acute). In separate Cox models, long-term chronic use was associated with a 4.7-fold higher risk of HCV seroconversion (vs naive/acute use 95% CI, 3.9-5.8), and long-term higher-dose use (≥90 MEQ) was associated with a 5.1-fold higher risk (vs naive/acute use 95% CI, 3.7-7.1)., Conclusions and Relevance: In this cohort study of people with more than 1 HCV test, long-term prescription opioid therapy for noncancer pain was associated with a higher risk of HCV seroconversion among individuals who were injection drug use-naive at baseline or at prescription opioid initiation. These results suggest injection drug use initiation risk is higher among people dispensed long-term therapy and may be useful for informing approaches to identify and prevent HCV infection. These findings should not be used to justify abrupt discontinuation of long-term therapy, which could increase risk of harms.
- Published
- 2022
- Full Text
- View/download PDF
6. Association of Medical Stimulants With Mortality in the US From 2010 to 2017.
- Author
-
Black JC, Bau GE, Iwanicki JL, and Dart RC
- Subjects
- Adult, Amphetamine adverse effects, Cocaine adverse effects, Drug Overdose epidemiology, Drug Overdose mortality, Female, Humans, Male, Methamphetamine adverse effects, Middle Aged, Central Nervous System Stimulants adverse effects, Drug Overdose etiology
- Published
- 2021
- Full Text
- View/download PDF
7. Abuse-Deterrent Formulations of Prescription Opioids.
- Author
-
Dart RC, Severtson SG, and Green JL
- Subjects
- Female, Humans, Male, Analgesics, Opioid chemistry, Opioid-Related Disorders epidemiology, Opioid-Related Disorders prevention & control, Oxycodone chemistry, Prescription Drugs chemistry
- Published
- 2015
- Full Text
- View/download PDF
8. Requirements and definitions in conflict of interest policies of medical journals.
- Author
-
Blum JA, Freeman K, Dart RC, and Cooper RJ
- Subjects
- Authorship, Bibliometrics, Cross-Sectional Studies, Financial Support, Guidelines as Topic, Journal Impact Factor, Medicine, Conflict of Interest, Disclosure standards, Editorial Policies, Journalism, Medical standards, Periodicals as Topic standards, Periodicals as Topic statistics & numerical data
- Abstract
Context: Conflicts of interest (COIs) may influence medical literature. However, it is unclear whether medical journals have consistent policies for defining and soliciting COI disclosures., Objective: To determine the prevalence of author COI policies, requirements for signed disclosure statements, and variability in COI definitions among medical journals., Design: A cross-sectional survey of Instructions for Authors and manuscript submission documents, including authorship responsibility forms, for high-impact medical journals across 35 subject categories available from March through October 2008., Main Outcome Measure: Presence of language referring to COI disclosure in the Instructions for Authors or manuscript submission documents., Results: Of 256 journals, 89% had author COI policies. Fifty-four percent required authors to sign a disclosure statement, and 77% provided definitions of COI. Most definitions were limited to direct financial relationships; a minority of journals requested disclosure of other potential conflicts such as personal relationships (42%), paid expert testimony (42%), relationships with other organizations (26%), or travel grants (12%). The prevalence of policies varied by subject category: all internal medicine, respiratory medicine, and toxicology journals studied had comprehensive COI definitions, with 19 of these 24 journals requiring signed disclosure attestations. In contrast, 6 of 19 geriatrics, radiology, and rehabilitation journals requested author COI disclosure. Most journals that officially endorsed International Committee of Medical Journal Editors guidelines had COI policies (68/69), compared with 84% of journals not endorsing the guidelines (158/187)., Conclusions: In 2008, most medical journals with relatively high impact factors had author COI policies available for public review. Among journals, there was substantial variation in policies for solicitation of author COIs and in definitions of COI.
- Published
- 2009
- Full Text
- View/download PDF
9. Tramadol abuse and dependence among physicians.
- Author
-
Adams EH, Dart RC, Knisely JS, and Schnoll SH
- Subjects
- Humans, Opioid-Related Disorders epidemiology, Physicians statistics & numerical data, Tramadol
- Published
- 2005
- Full Text
- View/download PDF
10. Extended-release acetaminophen overdose.
- Author
-
Cetaruk EW, Dart RC, Horowitz RS, and Hurlbut KM
- Subjects
- Acetaminophen administration & dosage, Analgesics, Non-Narcotic administration & dosage, Delayed-Action Preparations, Drug Overdose, Humans, Acetaminophen poisoning, Analgesics, Non-Narcotic poisoning
- Published
- 1996
11. Toxic shock syndrome associated with the use of the vaginal contraceptive sponge.
- Author
-
Dart RC and Levitt MA
- Subjects
- Adolescent, Female, Humans, Menstruation, Contraceptive Devices, Female adverse effects, Shock, Septic etiology
- Published
- 1985
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.